Table 3: Descriptive data of the groups allocated according to the demographic and disease-related characteristics features of the participants.
|
Total n (%) |
Remission n (%) |
Low DA n (%) |
Moderate-High DA n (%) |
|
|
Gender- Female |
120 (83.9) |
54 (80.6) |
19 (79.2) |
47 (90.4) |
|
-Male |
23 (16.1) |
13 (19.4) |
5 (20.8) |
5 (9.6) |
|
BMI - Normal |
45 (31.5) |
26 (38.8) |
5 (20.8) |
14 (26.9) |
|
-Owerweight |
98 (68.5) |
41 (61.2) |
19 (79.2) |
38 (73.1) |
|
Duration of disease (years) -Early stage (≤ 2 years) |
41 (28.7) |
18 (26.9) |
6 (25.0) |
17 (32.7) |
|
-Late stage (> 2 years) |
102 (71.3) |
49 (73.1) |
18 (75.0) |
35 (67.3) |
|
Morning stiffness (sec) -≤ 60 sec |
124 (86.7) |
63 (94.0) |
20 (83.3) |
41 (78.8) |
|
> 60 sec |
19 (13.3) |
4 (6.0) |
4 (16.7) |
11 (21.2) |
|
Presence of deformity -Yes |
49 (34.3) |
17 (25.4) |
9 (37.5) |
23 (44.2) |
|
-No |
94 (65.7) |
50 (74.6) |
15 (62.5) |
29 (55.8) |
|
Presence of nodules -Yes |
24 (16.8) |
8 (11.9) |
2 (8.3) |
14 (26.9) |
|
-No |
119 (83.2) |
59 (88.1) |
22 (91.7) |
38 (73.1) |
|
Dry eye -Yes |
65 (45.5) |
30 (44.8) |
9 (37.5) |
26 (50.0) |
|
-No |
78 (54.5) |
37 (55.2) |
15 (62.5) |
26 (50.0) |
|
Nailabnormalities -Yes |
39 (27.3) |
18 (26.9) |
6 (25.0) |
15 (28.8) |
|
-No |
104 (72.7) |
49 (73.1) |
18 (75.0) |
37 (71.2) |
|
Raynaud's phenomenon -Yes |
30 (21.0) |
9 (13.4) |
7 (29.2) |
14 (26.9) |
|
-No |
113 (79.0) |
58 (86.6) |
17 (70.8) |
38 (73.1) |
|
Osteoporosis -Yes |
43 (30.1) |
15 (22.4) |
4 (16.7) |
27 (51.9) |
|
-No |
97 (67.8) |
52 (77.6) |
20 (83.3) |
25 (48.1) |
|
Dyspnea at rest -Yes |
28 (19.6) |
11 (16.4) |
2 (8.3) |
15 (28.8) |
|
-No |
115 (80.4) |
56 (83.6) |
22 (91.7) |
37 (71.2) |
|
Exertional dyspnea -Yes |
64 (44.8) |
24 (35.8) |
10 (41.7) |
30 (57.7) |
|
-No |
79 (55.2) |
43 (64.2) |
14 (58.3) |
22 (42.3) |
DA: Disease activity.